Human CD30 Ligand/TNFSF8 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB7741SP	R&D Systems MAB7741SP	25 μg
MAB7741100	R&D Systems MAB7741100	100 μg

Description

CD30 Ligand/TNFSF8 Monoclonal antibody specifically detects CD30 Ligand/TNFSF8 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Neutralization

Specifications

• Antigen: CD30 Ligand/TNFSF8
• Dilution: Flow Cytometry 0.25 ug/10⁶ cells, Immunohistochemistry 5-25 ug/mL, Neutralization 0.3-3 ug/mL
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
• Gene Alias: CD153, CD153 antigen, CD30 antigen ligand, CD30L, CD30-L, CD30LCD30 ligand, CD30LGMGC138144, TNFSF8, tumor necrosis factor (ligand) superfamily, member 8, tumor necrosis factor ligand superfamily member 8
• Immunogen: Mouse myeloma cell line NS0-derived human CD30 Ligand/TNFSF8., Gln63-Asp234, Accession # P32971
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.

• Clone: 116632
• Applications: Flow Cytometry, Immunohistochemistry, Neutralization
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: P32971
• Gene ID (Entrez): 944
• Isotype: IgG2a
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.